No abstract

No abstract

No abstract

No abstract

No abstract

A growing number of vehicles are being transformed into semi-autonomous vehicles (Level 2 autonomy) by relying on advanced driver assistance systems (ADAS) to improve the driving experience. However, the increasing complexity and connectivity of ADAS expose the vehicles to safety-critical faults and attacks. This paper investigates the resilience of a widelyused ADAS against safety-critical attacks that target the control system at opportune times during different driving scenarios and cause accidents. Experimental results show that our proposed Context-Aware attacks can achieve an 83.4% success rate in causing hazards, 99.7% of which occur without any warnings. These results highlight the intolerance of ADAS to safety-critical attacks and the importance of timely interventions by human drivers or automated recovery mechanisms to prevent accidents.

No abstract

The development of a fully autonomous artificial pancreas system (APS) to independently regulate the glucose levels of a patient with Type 1 diabetes has been a long-standing goal of diabetes research. A significant barrier to progress is the difficulty of testing new control algorithms and safety features, since clinical trials are timeand resource-intensive. To facilitate ease of validation, we propose an open-source APS testbed by integrating APS controllers with two state-of-the-art glucose simulators and a novel fault injection engine. The testbed is able to reproduce the blood glucose trajectories of real patients from a clinical trial conducted over six months. We evaluate the performance of two closed-loop control algorithms (OpenAPS and Basal Bolus) using the testbed and find that more advanced control algorithms are able to keep blood glucose in a safe region 93.49% and 79.46% of the time on average, compared with 66.18% of the time for the clinical trial. The fault injection engine simulates the real recalls and adverse events reported to the U.S. Food and Drug Administration (FDA) and demonstrates the resilience of the controller in hazardous conditions. We used the testbed to generate 2.5 years of synthetic data representing 20 different patient profiles with realistic adverse event scenarios, which would have been expensive and risky to collect in a clinical trial. The proposed testbed is a valid tool that can be used by the research community to demonstrate the effectiveness of different control algorithms and safety features for APS. CCS CONCEPTS• Computer systems organization → Embedded and cyberphysical systems; Dependable and fault-tolerant systems and networks; • Applied computing → Life and medical sciences.